- Home
- VYNE vs CLIR Comparison
VYNE vs CLIR Comparison
Compare VYNE & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- CLIR
- Stock Information
- Founded
- VYNE 2003
- CLIR 2008
- Country
- VYNE United States
- CLIR United States
- Employees
- VYNE N/A
- CLIR N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- VYNE Health Care
- CLIR Industrials
- Exchange
- VYNE Nasdaq
- CLIR Nasdaq
- Market Cap
- VYNE 41.9M
- CLIR 41.7M
- IPO Year
- VYNE 2018
- CLIR 2012
- Fundamental
- Price
- VYNE $2.98
- CLIR $1.23
- Analyst Decision
- VYNE Strong Buy
- CLIR Strong Buy
- Analyst Count
- VYNE 2
- CLIR 1
- Target Price
- VYNE $6.88
- CLIR $6.00
- AVG Volume (30 Days)
- VYNE 122.3K
- CLIR 199.4K
- Earning Date
- VYNE 11-07-2024
- CLIR 11-14-2024
- Dividend Yield
- VYNE N/A
- CLIR N/A
- EPS Growth
- VYNE N/A
- CLIR N/A
- EPS
- VYNE N/A
- CLIR N/A
- Revenue
- VYNE $493,000.00
- CLIR $4,280,000.00
- Revenue This Year
- VYNE $32.31
- CLIR $69.16
- Revenue Next Year
- VYNE N/A
- CLIR $440.76
- P/E Ratio
- VYNE N/A
- CLIR N/A
- Revenue Growth
- VYNE 39.27
- CLIR 263.02
- 52 Week Low
- VYNE $1.57
- CLIR $0.62
- 52 Week High
- VYNE $4.09
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- VYNE 59.02
- CLIR 76.79
- Support Level
- VYNE $2.65
- CLIR $0.85
- Resistance Level
- VYNE $3.05
- CLIR $1.28
- Average True Range (ATR)
- VYNE 0.23
- CLIR 0.09
- MACD
- VYNE -0.05
- CLIR 0.03
- Stochastic Oscillator
- VYNE 34.57
- CLIR 84.78
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.